CF PharmTech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	432.52	607.75	556.42	349.13	41.99
Revenue Growth (YoY)	-28.83%	9.22%	59.38%	731.54%	764.11%
Cost of Revenue	104.58	117.67	101.85	83.46	21.78
Gross Profit	327.94	490.09	454.57	265.67	20.2
Selling, General & Admin	218.3	363.37	319.93	243.81	138.88
Research & Development	124.55	121.85	132.79	107.23	98.46
Other Operating Expenses	-0.1	-	-	-	0.77
Operating Expenses	348.08	486.51	452.4	351.45	238.1
Operating Income	-20.15	3.58	2.17	-85.78	-217.9
Interest Expense	-2.54	-1.78	-0.17	-0.16	-0.14
Interest & Investment Income	2.15	0.61	3.92	4.29	20.71
Earnings From Equity Investments	-0.17	-0.07	-0.1	-	-
Currency Exchange Gain (Loss)	-	-	-0.2	2.5	-1.76
Other Non Operating Income (Expenses)	4.06	16.85	16.82	8.54	-0.08
EBT Excluding Unusual Items	-16.65	19.18	22.44	-70.62	-199.18
Gain (Loss) on Sale of Investments	3.24	-	-	-	0.44
Gain (Loss) on Sale of Assets	-	-	-	-	-0.01
Asset Writedown	-	-	-	-	-0.02
Other Unusual Items	-	-	-	-	4.57
Pretax Income	-13.41	19.18	22.44	-70.62	-194.2
Income Tax Expense	-15.89	-1.9	-9.28	-21.22	-62.47
Net Income	2.49	21.09	31.73	-49.4	-131.73
Net Income to Common	2.49	21.09	31.73	-49.4	-131.73
Net Income Growth	-88.22%	-33.53%	-	-	-
Shares Outstanding (Basic)	378	371	371	371	-
Shares Outstanding (Diluted)	378	371	371	371	-
Shares Change (YoY)	1.85%	-	-	-	-
EPS (Basic)	0.01	0.06	0.09	-0.13	-
EPS (Diluted)	0.01	0.06	0.09	-0.13	-
EPS Growth	-88.43%	-33.53%	-	-	-
Free Cash Flow	-	-71.2	1.65	-45.72	-247.95
Free Cash Flow Per Share	-	-0.19	0.00	-0.12	-
Gross Margin	75.82%	80.64%	81.69%	76.09%	48.12%
Operating Margin	-4.66%	0.59%	0.39%	-24.57%	-518.98%
Profit Margin	0.57%	3.47%	5.70%	-14.15%	-313.74%
Free Cash Flow Margin	-	-11.72%	0.30%	-13.10%	-590.55%
EBITDA	33.55	57.27	50.53	-51.53	-191.71
EBITDA Margin	7.76%	9.42%	9.08%	-14.76%	-
D&A For EBITDA	53.69	53.69	48.37	34.25	26.19
EBIT	-20.15	3.58	2.17	-85.78	-217.9
EBIT Margin	-4.66%	0.59%	0.39%	-24.57%	-
Advertising Expenses	-	181.7	165.59	93.59	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.